ArticleMolecular and clinical oncology2016

Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancer.

Michio Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.